fp

Latanoprost acid is a selective agonist of prostanoid receptors and inhibits RANKL-induced osteoclastogenesis and function through the inhibition of c-fos NFATc1 pathway. Latanoprost acid can be used in studies about lowering pressure inside the eyes.

FP-21399, an HIV fusion inhibitor, is used potentially for the treatment of HIV infection.

FP-biotin is a potent organophosphorus toxicant ideal for identifying novel biomarkers of organophosphorus exposure. It measures FAAH, ABHD6, and MAG-lipase activity specifically in plasma studies, thanks to the efficient purification of biotinylated peptides through binding to immobilized avidin beads.

DFP00173 is a potent and selective aquaporin 3 (AQP3) inhibitor, with an IC50 of approximately 0.1-0.4 μM for both mouse and human AQP3. It demonstrates selectivity for AQP3 compared to homologous AQP subtypes AQP7 and AQP9.

FPL 55712 is a leukotriene receptor and SRS-A antagonist that inhibits bronchoconstriction and can be used in studies of asthma and coronary artery thrombosis.

FPL-62129 is a calcium channel antagonist and a novel angiotensin-converting enzyme inhibitor with vasodilator activity for the study of cardiovascular disease.

(2RS)-FPMPA（FPMPA） has antiviral activity with an IC50 value of 1.85 μM measured in human MT12 cells infected with SHIV (DH4R).

FPMPA PM is a derivative of FPMPA, a selective adenosine A3 receptor agonist with anti-inflammatory, analgesic and neuroprotective activities.

Cefpiramide acid (Cefpiramidum) is a third-generation cephalosporin antibiotic.

L-4FPG is a Glycine derivative, inhibits the neutral amino acid transporters ASCT1 and ASCT2.

Cefpirome sulfate (HR-810 sulfate) is a fourth-generation cephalosporin antibiotic.

Cefpodoxime is an oral third generation cephalosporin antibiotic. It is active against most Gram positive and Gram negative bacteria. It is commonly used to treat acute otitis media, pharyngitis, and sinusitis. Cefpodoxime proxetil is a prodrug which is a

FPR A14 is an agonist of formyl peptide receptor (FPR) and induces cell differentiation.

FPL 62064 is a potent dual inhibitor of 5-lipoxygenase (5-LOX) and COX (IC50 of 3.5 μM and 3.1 μM for RBL-1 cytosolic 5-lipoxygenase and prostaglandin synthetase, respectively).

FP0429 is an agonist of mGlu4.

Notoginsenoside FP2 is a natural product isolated from the fruit pedicels of Panax notoginseng and can be used in studies about the treatment of cardiovascular diseases.

AFP464 (NSC710464) free base is an active HIF-1α inhibitor (IC50: 0.25 μM) and a potent aryl hydrocarbon receptor (AhR) activator.

Cefprozil monohydrate (Cefprozil) is a second-generation cephalosporin-type antibiotic.

Cefprozil (Cefzil) is a novel cephalosporin antibiotic with antiviral activity for the study of immune system disorders.

FPA-124 is a cell-permeable copper complex that acts as a selective Akt (protein kinase B) inhibitor interacting with the homology (PH) and kinase structural domains of Akt to induce apoptosis. It has the advantage of being highly potent and exhibits dose-dependent growth inhibition in a variety of cancer cell lines.

RXFP3 4 agonist 1 is a relaxin family peptide 3 4 receptor (RXFP3 4) agonist(EC50s of 82 2 nM, respectivley).

6-Maleimidocaproic acid-PFP ester is a hydrocarbon-based PROTAC linker suitable for synthesizing PROTACs [1].

Acid-PEG3-PFP ester is a PEG-based linker for PROTACs that joins two essential ligands, facilitating the formation of PROTAC molecules and enabling selective protein degradation by leveraging the ubiquitin-proteasome system within cells.

Azido-PEG1-PFP ester, a PEG-based linker for PROTACs, connects two essential ligands critical for forming PROTAC molecules and enables selective protein degradation by leveraging the ubiquitin-proteasome system within cells.